Tandem Diabetes Care, Inc. (TNDM) vs First Tracks Biotherapeutics Inc (TRAX)

A side-by-side comparison of Tandem Diabetes Care, Inc. and First Tracks Biotherapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Tandem Diabetes Care, Inc. logo
TNDM
Tandem Diabetes Care, Inc.
$1.11B
$16.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
First Tracks Biotherapeutics Inc logo
TRAX
First Tracks Biotherapeutics Inc
$1.10B
$31.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — TNDM vs TRAX

growth of $100 · dividends reinvested · last 1y
TNDM -11.2% (-11.2%/yr)TRAX +73.6% (+73.6%/yr)TRAX compounded faster over this window
100150200250Start $100$89$174
TNDM TRAX

TNDM vs TRAX: by the numbers

  • •TNDM is the larger company ($1.11B vs $1.10B market cap).
  • •Both run net losses; TRAX's is the smaller (0.00% vs -6.08% net margin).

Metrics side by side

Valuation

MetricTNDMTRAX
P/S ratio1.06N/A
P/B ratio8.496.49

Profitability

MetricTNDMTRAX
Gross margin56.01%0.00%
Operating margin-4.13%0.00%
Net margin-6.08%0.00%
ROE-48.56%-57.77%
ROIC-4.77%-59.76%

Growth (annualized)

MetricTNDMTRAX
Revenue CAGR (5Y)11.48%N/A
Total return CAGR (5Y)-32.93%N/A

Go deeper

Full TNDM analysisFull TRAX analysisInteractive comparison tool

Dig into the metrics

Tandem Diabetes Care ROEFirst Tracks Biotherapeutics ROETandem Diabetes Care operating marginFirst Tracks Biotherapeutics operating marginTandem Diabetes Care revenue growthFirst Tracks Biotherapeutics revenue growthTandem Diabetes Care free cash flowFirst Tracks Biotherapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.